Validation and next-generation update of a DNA methylation–based recurrence predictor for meningioma: A multicenter prospective study
This next-generation DNA methylation-based meningioma outcome predictor significantly outperforms the 2021 WHO grading in predicting time to recurrence. We make this available as a point-and-click tool that will improve prognostication, inform patient selection for RT, and allow for molecularly stratified clinical trials.
Authors
- Christopher M. Wilson (ORCID: https://orcid.org/0000-0003-3307-1449)
- Farshad Nassiri (ORCID: https://orcid.org/0000-0002-0797-3425)
- Aaron Cohen‐Gadol (ORCID: https://orcid.org/0000-0002-4946-1524)
- Matthew Blackwell
- Olivia Singh
- Zeel Patel (ORCID: https://orcid.org/0000-0002-6137-0510)
- Felix Behling (ORCID: https://orcid.org/0000-0002-1083-1276)
- Chloe Gui (ORCID: https://orcid.org/0000-0002-6685-1970)
- Joseph G. Davis (ORCID: https://orcid.org/0000-0001-9871-8771)
- Noah Burket (ORCID: https://orcid.org/0000-0002-6214-8655)
- Silky Chotai (ORCID: https://orcid.org/0000-0001-5981-3231)
- David Capper (ORCID: https://orcid.org/0000-0003-1945-497X)
- Marcos Soares Tatagiba (ORCID: https://orcid.org/0000-0002-1627-9937)
- Anthony Alfonso (ORCID: https://orcid.org/0000-0001-9045-6498)
- Mohamed A. Zaazoue (ORCID: https://orcid.org/0000-0002-6755-6308)
- Derek S. Tsang (ORCID: https://orcid.org/0000-0002-9762-6901)
- Jill S. Barnholtz‐Sloan (ORCID: https://orcid.org/0000-0001-6190-9304)
- Alireza Mansouri (ORCID: https://orcid.org/0000-0002-7442-7539)
- Andrew Ajisebutu
- Justin Z. Wang (ORCID: https://orcid.org/0000-0001-8998-7443)
- Yasin Mamatjan (ORCID: https://orcid.org/0000-0002-8807-2927)
- Mark W. B. Wilson (ORCID: https://orcid.org/0000-0002-1957-2979)
- Kenneth Aldape (ORCID: https://orcid.org/0000-0001-5119-7550)
- Yosef Ellenbogen (ORCID: https://orcid.org/0000-0003-1390-1361)
- Ramneet Kaloti
- Gelareh Mohammed Zadeh (ORCID: https://orcid.org/0000-0002-6637-4502)
- Felix Ehret (ORCID: https://orcid.org/0000-0001-6177-1755)
- Qingxia Wei (ORCID: https://orcid.org/0000-0002-7723-6180)
- Julio Sosa (ORCID: https://orcid.org/0000-0001-5516-5724)
- Lola B. Chambless (ORCID: https://orcid.org/0000-0001-5864-5387)
- Jenna Koenig (ORCID: https://orcid.org/0000-0001-6952-955X)
- Andrew Edward Sloan (ORCID: https://orcid.org/0000-0001-9607-5063)
- Sheila Mansouri (ORCID: https://orcid.org/0000-0002-7255-207X)
- Ghazaleh Tabatabai (ORCID: https://orcid.org/0000-0002-3542-8782)
- Andrew Gao (ORCID: https://orcid.org/0000-0002-2204-3277)
- Alexander Landry (ORCID: https://orcid.org/0000-0002-7250-8466)
- Vikas Patil (ORCID: https://orcid.org/0000-0001-9564-4420)
- Piiamaria Virtanen (ORCID: https://orcid.org/0000-0002-1006-6009)
- Parnian Habibi
- Rebecca Yakubov
Institutions
- University Health Network (CA)
- University of Toronto (CA)
- Washington University in St. Louis (US)
- Oklahoma State University Medical Center (US)
- Princess Margaret Cancer Centre (CA)
- Humboldt-Universität zu Berlin (DE)
- Center for Neuro-Oncology (US)
- German Cancer Society (DE)
- National Cancer Institute (US)
- Hertie Institute for Clinical Brain Research (DE)
- Center for Cancer Research (US)
- Neurological Surgery (US)
- Division of Cancer Epidemiology and Genetics
- Deutsches Konsortium für Translationale Krebsforschung (DE)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
- University of Tübingen (DE)
- Penn State Milton S. Hershey Medical Center (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Neuro-Oncology
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1093/neuonc/noae236
- Citations
- 6
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 2.32
Funders
- Vanderbilt University
- University of Pennsylvania
- Pennsylvania State University
- Deutsches Krebsforschungszentrum
- Vanderbilt University Medical Center
- Humboldt-Universität zu Berlin
- Freie Universität Berlin
- Deutschen Konsortium für Translationale Krebsforschung
- Canadian Institutes of Health Research
- National Cancer Institute
- Division of Cancer Epidemiology and Genetics, National Cancer Institute
- Center for Biomedical Informatics and Information Technology, National Cancer Institute